Ascendis Financial Statements From 2010 to 2024

A1SN34 Stock  BRL 54.00  5.16  10.57%   
Ascendis Pharma financial statements provide useful quarterly and yearly information to potential Ascendis Pharma AS investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ascendis Pharma financial statements helps investors assess Ascendis Pharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ascendis Pharma's valuation are summarized below:
Ascendis Pharma AS does not presently have any fundamental signals for analysis.
Check Ascendis Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ascendis Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ascendis financial statements analysis is a perfect complement when working with Ascendis Pharma Valuation or Volatility modules.
  
This module can also supplement various Ascendis Pharma Technical models . Check out the analysis of Ascendis Pharma Correlation against competitors.

Ascendis Pharma AS Company Shares Outstanding Analysis

Ascendis Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Ascendis Pharma Shares Outstanding

    
  57.03 M  
Most of Ascendis Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ascendis Pharma AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Ascendis Pharma AS has 57.03 M of shares currently outstending. This is 68.41% lower than that of the Healthcare sector and 46.63% lower than that of the Biotechnology industry. The shares outstanding for all Brazil stocks is 90.03% higher than that of the company.

Ascendis Pharma AS Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ascendis Pharma's current stock value. Our valuation model uses many indicators to compare Ascendis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascendis Pharma competition to find correlations between indicators driving Ascendis Pharma's intrinsic value. More Info.
Ascendis Pharma AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ascendis Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ascendis Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Ascendis Pharma Financial Statements

Ascendis Pharma stakeholders use historical fundamental indicators, such as Ascendis Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ascendis Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ascendis Pharma's assets and liabilities are reflected in the revenues and expenses on Ascendis Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ascendis Pharma AS. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Ascendis Stock

When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports:
Check out the analysis of Ascendis Pharma Correlation against competitors.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.